Spoken Alpha
SOLENO THERAPEUTICS INC
SOLENO THERAPEUTICS INC is a Healthcare company operating in Biotechnology with a $2.76B market cap.
Most recent earnings call: Q4 FY25 on Feb 26, 2026.
4 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-05-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SLNO.
$ curl https://api.spokenalpha.com/v1/companies/SLNOFAQ
Spoken Alpha indexes SLNO's earnings call transcripts at https://spokenalpha.com/companies/SLNO. Each call links to attributed speakers and parsed analyst Q&A. SOLENO THERAPEUTICS INC's own investor relations page is at https://investors.soleno.life/.
SOLENO THERAPEUTICS INC (SLNO) held its most recent earnings call on 2026-02-26, covering fiscal Q4 2025.
SOLENO THERAPEUTICS INC (SLNO) operates in the Healthcare sector (Biotechnology industry).